gentamicin has been researched along with Communicable Diseases in 7 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Communicable Diseases: An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Gentamicin pharmacokinetic parameters were estimated by non-linear regression analysis, assuming a one-compartment model and first-order elimination from the central compartment." | 2.68 | Expanded gentamicin volume of distribution in critically ill adult patients receiving total parenteral nutrition. ( Abad, J; Jiménez, NV; Ordovás, JP; Ronchera-Oms, CL; Tormo, C, 1995) |
| "Few studies on neonatal severe bacterial infection are available in LMICs." | 1.91 | Incidence and risk factors of neonatal bacterial infections: a community-based cohort from Madagascar (2018-2021). ( Abdou, AY; Andriamarohasina, L; Andrianirina, ZZ; Collard, JM; Crucitti, T; Delarocque-Astagneau, E; Devred, I; Guillemot, D; Harimanana, A; Herindrainy, P; Hivernaud, D; Huynh, BT; Kermorvant-Duchemin, E; Rambliere, L; Randrianirina, F; Ratsima, EH, 2023) |
| "Population pharmacokinetic parameters of gentamicin in preterm neonates on a once-daily dosage regimen of 3." | 1.30 | Population pharmacokinetics of gentamicin in preterm neonates: evaluation of a once-daily dosage regimen. ( Fleer, A; Krediet, TG; Rademaker, CM; van Asten, P; van Dijk, A; Vervelde, ML, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Franco, S | 1 |
| Rampersad, D | 1 |
| Mesa, D | 1 |
| Hammerschlag, MR | 1 |
| Wu, X | 1 |
| Wang, C | 1 |
| He, L | 1 |
| Xu, H | 1 |
| Jing, C | 1 |
| Chen, Y | 2 |
| Lin, A | 1 |
| Deng, J | 1 |
| Cao, Q | 1 |
| Deng, H | 1 |
| Cai, H | 1 |
| Yang, J | 1 |
| Zhang, T | 1 |
| Huang, Y | 1 |
| Hao, J | 1 |
| Yu, H | 1 |
| Devred, I | 1 |
| Rambliere, L | 1 |
| Herindrainy, P | 1 |
| Andriamarohasina, L | 1 |
| Harimanana, A | 1 |
| Randrianirina, F | 1 |
| Ratsima, EH | 1 |
| Hivernaud, D | 1 |
| Kermorvant-Duchemin, E | 1 |
| Andrianirina, ZZ | 1 |
| Abdou, AY | 1 |
| Delarocque-Astagneau, E | 1 |
| Guillemot, D | 1 |
| Crucitti, T | 1 |
| Collard, JM | 1 |
| Huynh, BT | 1 |
| Kongtorp, RT | 1 |
| Kjerstad, A | 1 |
| Taksdal, T | 1 |
| Guttvik, A | 1 |
| Falk, K | 1 |
| Ronchera-Oms, CL | 1 |
| Tormo, C | 1 |
| Ordovás, JP | 1 |
| Abad, J | 1 |
| Jiménez, NV | 1 |
| Vervelde, ML | 1 |
| Rademaker, CM | 1 |
| Krediet, TG | 1 |
| Fleer, A | 1 |
| van Asten, P | 1 |
| van Dijk, A | 1 |
| Finland, M | 1 |
1 review available for gentamicin and Communicable Diseases
| Article | Year |
|---|---|
Gentamicin: antibacterial activity, clinical pharmacology and clinical applications.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Chemical Phenomena; Chemistry; Communicable Diseases; Drug | 1969 |
1 trial available for gentamicin and Communicable Diseases
| Article | Year |
|---|---|
Expanded gentamicin volume of distribution in critically ill adult patients receiving total parenteral nutrition.
Topics: Adult; Aged; Anti-Bacterial Agents; Communicable Diseases; Critical Illness; Female; Fluorescence Po | 1995 |
5 other studies available for gentamicin and Communicable Diseases
| Article | Year |
|---|---|
Treatment options for neonatal infections in the post-cefotaxime era.
Topics: Ampicillin; Anti-Bacterial Agents; Calcium; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalos | 2022 |
Antimicrobial resistance profile of methicillin-resistant
Topics: Abscess; Anti-Bacterial Agents; Child; Child, Preschool; Clindamycin; Communicable Diseases; Drug Re | 2023 |
Incidence and risk factors of neonatal bacterial infections: a community-based cohort from Madagascar (2018-2021).
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Child; Child, Preschool; Communicable Disease | 2023 |
Heart and skeletal muscle inflammation in Atlantic salmon, Salmo salar L: a new infectious disease.
Topics: Animals; Aquaculture; Communicable Diseases; Fish Diseases; Gentamicins; Histological Techniques; Mu | 2004 |
Population pharmacokinetics of gentamicin in preterm neonates: evaluation of a once-daily dosage regimen.
Topics: Age Factors; Communicable Diseases; Gentamicins; Humans; Infant, Newborn; Infant, Premature; Infant, | 1999 |